Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-20

Clinical Trial Update: Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing fluoxetine to EMDR therapy for post-traumatic stress disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

Sponsor: Boston University | Conditions: Stress Disorders, Post-Traumatic | Phase 3 | Status: COMPLETED